MAPK1 and viral infectious disease: Additionally, virus infection alone (without PMA treatment) also triggered ERK2-AS mediated NP phosphorylation to the extent comparable to the PMA treated set (Fig 1F, lane 6), thus indicating robust activation of the MAPK pathway, specifically ERK2, during influenza virus infection.